203 related articles for article (PubMed ID: 21317456)
1. Homologous recombination repair is essential for repair of vosaroxin-induced DNA double-strand breaks.
Hawtin RE; Stockett DE; Wong OK; Lundin C; Helleday T; Fox JA
Oncotarget; 2010 Nov; 1(7):606-619. PubMed ID: 21317456
[TBL] [Abstract][Full Text] [Related]
2. Voreloxin is an anticancer quinolone derivative that intercalates DNA and poisons topoisomerase II.
Hawtin RE; Stockett DE; Byl JA; McDowell RS; Nguyen T; Arkin MR; Conroy A; Yang W; Osheroff N; Fox JA
PLoS One; 2010 Apr; 5(4):e10186. PubMed ID: 20419121
[TBL] [Abstract][Full Text] [Related]
3. The preclinical discovery of vosaroxin for the treatment of acute myeloid leukemia.
Paubelle E; Zylbersztejn F; Thomas X
Expert Opin Drug Discov; 2017 Jul; 12(7):747-753. PubMed ID: 28504025
[TBL] [Abstract][Full Text] [Related]
4. Radiosensitization by the novel DNA intercalating agent vosaroxin.
Gordon IK; Graves C; Kil WJ; Kramp T; Tofilon P; Camphausen K
Radiat Oncol; 2012 Feb; 7():26. PubMed ID: 22369205
[TBL] [Abstract][Full Text] [Related]
5. Homologous recombination is the principal pathway for the repair of DNA damage induced by tirapazamine in mammalian cells.
Evans JW; Chernikova SB; Kachnic LA; Banath JP; Sordet O; Delahoussaye YM; Treszezamsky A; Chon BH; Feng Z; Gu Y; Wilson WR; Pommier Y; Olive PL; Powell SN; Brown JM
Cancer Res; 2008 Jan; 68(1):257-65. PubMed ID: 18172318
[TBL] [Abstract][Full Text] [Related]
6. The role of nonhomologous DNA end joining, conservative homologous recombination, and single-strand annealing in the cell cycle-dependent repair of DNA double-strand breaks induced by H(2)O(2) in mammalian cells.
Frankenberg-Schwager M; Becker M; Garg I; Pralle E; Wolf H; Frankenberg D
Radiat Res; 2008 Dec; 170(6):784-93. PubMed ID: 19138034
[TBL] [Abstract][Full Text] [Related]
7. Enhancement of radiosensitivity by the novel anticancer quinolone derivative vosaroxin in preclinical glioblastoma models.
Gravina GL; Mancini A; Mattei C; Vitale F; Marampon F; Colapietro A; Rossi G; Ventura L; Vetuschi A; Di Cesare E; Fox JA; Festuccia C
Oncotarget; 2017 May; 8(18):29865-29886. PubMed ID: 28415741
[TBL] [Abstract][Full Text] [Related]
8. Molecular and Pharmacologic Properties of the Anticancer Quinolone Derivative Vosaroxin: A New Therapeutic Agent for Acute Myeloid Leukemia.
Jamieson GC; Fox JA; Poi M; Strickland SA
Drugs; 2016 Sep; 76(13):1245-1255. PubMed ID: 27484675
[TBL] [Abstract][Full Text] [Related]
9. Venetoclax Synergistically Enhances the Anti-leukemic Activity of Vosaroxin Against Acute Myeloid Leukemia Cells Ex Vivo.
Liu F; Knight T; Su Y; Edwards H; Wang G; Wang Y; Taub JW; Lin H; Sun L; Ge Y
Target Oncol; 2019 Jun; 14(3):351-364. PubMed ID: 31115744
[TBL] [Abstract][Full Text] [Related]
10. Topoisomerase II-mediated DNA damage is differently repaired during the cell cycle by non-homologous end joining and homologous recombination.
de Campos-Nebel M; Larripa I; González-Cid M
PLoS One; 2010 Sep; 5(9):. PubMed ID: 20824055
[TBL] [Abstract][Full Text] [Related]
11. Homologous recombination protects mammalian cells from replication-associated DNA double-strand breaks arising in response to methyl methanesulfonate.
Nikolova T; Ensminger M; Löbrich M; Kaina B
DNA Repair (Amst); 2010 Oct; 9(10):1050-63. PubMed ID: 20708982
[TBL] [Abstract][Full Text] [Related]
12. Therapeutic exploitation of tumor cell defects in homologous recombination.
Powell SN; Kachnic LA
Anticancer Agents Med Chem; 2008 May; 8(4):448-60. PubMed ID: 18473729
[TBL] [Abstract][Full Text] [Related]
13. The topoisomerase II inhibitor voreloxin causes cell cycle arrest and apoptosis in myeloid leukemia cells and acts in synergy with cytarabine.
Walsby EJ; Coles SJ; Knapper S; Burnett AK
Haematologica; 2011 Mar; 96(3):393-9. PubMed ID: 21134979
[TBL] [Abstract][Full Text] [Related]
14. Homologous recombination as a resistance mechanism to replication-induced double-strand breaks caused by the antileukemia agent CNDAC.
Liu X; Wang Y; Benaissa S; Matsuda A; Kantarjian H; Estrov Z; Plunkett W
Blood; 2010 Sep; 116(10):1737-46. PubMed ID: 20479284
[TBL] [Abstract][Full Text] [Related]
15. Influence of homologous recombinational repair on cell survival and chromosomal aberration induction during the cell cycle in gamma-irradiated CHO cells.
Wilson PF; Hinz JM; Urbin SS; Nham PB; Thompson LH
DNA Repair (Amst); 2010 Jul; 9(7):737-44. PubMed ID: 20434408
[TBL] [Abstract][Full Text] [Related]
16. Atypical retinoids ST1926 and CD437 are S-phase-specific agents causing DNA double-strand breaks: significance for the cytotoxic and antiproliferative activity.
Valli C; Paroni G; Di Francesco AM; Riccardi R; Tavecchio M; Erba E; Boldetti A; Gianni' M; Fratelli M; Pisano C; Merlini L; Antoccia A; Cenciarelli C; Terao M; Garattini E
Mol Cancer Ther; 2008 Sep; 7(9):2941-54. PubMed ID: 18790775
[TBL] [Abstract][Full Text] [Related]
17. Vosaroxin is a novel topoisomerase-II inhibitor with efficacy in relapsed and refractory acute myeloid leukaemia.
Hotinski AK; Lewis ID; Ross DM
Expert Opin Pharmacother; 2015 Jun; 16(9):1395-402. PubMed ID: 25958926
[TBL] [Abstract][Full Text] [Related]
18. DNA double-strand breaks associated with replication forks are predominantly repaired by homologous recombination involving an exchange mechanism in mammalian cells.
Arnaudeau C; Lundin C; Helleday T
J Mol Biol; 2001 Apr; 307(5):1235-45. PubMed ID: 11292338
[TBL] [Abstract][Full Text] [Related]
19. Non-homologous end joining is the responsible pathway for the repair of fludarabine-induced DNA double strand breaks in mammalian cells.
de Campos-Nebel M; Larripa I; González-Cid M
Mutat Res; 2008 Nov; 646(1-2):8-16. PubMed ID: 18812179
[TBL] [Abstract][Full Text] [Related]
20. Chloroethylnitrosourea-induced cell death and genotoxicity: cell cycle dependence and the role of DNA double-strand breaks, HR and NHEJ.
Nikolova T; Hennekes F; Bhatti A; Kaina B
Cell Cycle; 2012 Jul; 11(14):2606-19. PubMed ID: 22751442
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
